Goldstein Michael H. 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 7, 2022
Insider Transaction Report
Form 4
Goldstein Michael H.
Chief Medical Officer
Transactions
- Award
Common Stock
2022-02-03+63,333→ 313,335 total - Award
Stock Option (Right to Buy)
2022-02-03+190,000→ 190,000 totalExercise: $5.27Exp: 2032-02-02→ Common Stock (190,000 underlying)
Footnotes (3)
- [F1]On February 3, 2022, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Includes (i) 63,333 shares of common stock of the Company underlying unvested RSUs and (ii) 2 shares of the Company's common stock acquired under the 2014 Ocular Therapuetix, Inc. Employee Stock Purchase Plan on December 31, 2021.
- [F3]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.